MSB 2.10% $1.17 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-89

  1. 1,609 Posts.
    lightbulb Created with Sketch. 1691
    Tend to agree, but we have the ARDS trial which WILL be proven as efficacious to the gold standard if we get a positive result, so AGVHD may very much (shame for the kids) just have to take a back seat and wait for some time. Sad but true.

    Will be interesting, too, if COVID rips through the White House staff and Trump's family (Guardian graphic indicated just about every Trump, Giuliani, etc., has been in contact with Hope Hicks of late) and one or more end up on a ventilator. Hard to believe they wouldn't, at that point, be unaware of Rem-L and MSB's trial and ensure they get it.

    Surely they will demand more than just Hydroxychlorquine, Remdesivir and convalescent plasma for themselves, won't they? I mean, the rest of the country can eat cake, but not them!
    Last edited by dplane: 02/10/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.330B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 8683 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.